123 related articles for article (PubMed ID: 1385629)
1. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
Ormond PM; Basinger MA; Jones MM; Hande KR
J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629
[TBL] [Abstract][Full Text] [Related]
2. Alterations in atrial natriuretic peptide and its receptor levels in long-term, streptozotocin-induced, diabetes in rats.
Obineche E; Chandranath I; Adeghate E; Benedict S; Fahim M; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():223-34. PubMed ID: 17151304
[TBL] [Abstract][Full Text] [Related]
3. [Resistance to hemoconcentration but non hypotensive action of atrial natriuretic peptide in diabetes mellitus induced by streptozocin in the rat].
Valentin JP; Sechi LA; Humphreys MH
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1119-23. PubMed ID: 7755472
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cisplatin nephrotoxicity by exogenous atrial natriuretic peptide.
Deegan PM; Basinger MA; Jones MM; Hande KR
Toxicology; 1996 Jan; 106(1-3):159-66. PubMed ID: 8571387
[TBL] [Abstract][Full Text] [Related]
6. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
7. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat.
Rollín R; Mediero A; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2005 Mar; 11():216-24. PubMed ID: 15789000
[TBL] [Abstract][Full Text] [Related]
9. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M
J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
11. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
[TBL] [Abstract][Full Text] [Related]
12. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.
Ateşşahín A; Ceríbaşi AO; Yuce A; Bulmus O; Cikim G
Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):121-6. PubMed ID: 17244261
[TBL] [Abstract][Full Text] [Related]
13. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure.
Kurnik BR; Weisberg LS; Cuttler IM; Kurnik PB
J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949
[TBL] [Abstract][Full Text] [Related]
14. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
15. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats.
Atessahin A; Yilmaz S; Karahan I; Ceribasi AO; Karaoglu A
Toxicology; 2005 Sep; 212(2-3):116-23. PubMed ID: 15946783
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
Lee KW; Jeong JY; Lim BJ; Chang YK; Lee SJ; Na KR; Shin YT; Choi DE
Toxicology; 2009 Mar; 257(3):137-43. PubMed ID: 19152827
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
18. Naringenin attenuates cisplatin nephrotoxicity in rats.
Badary OA; Abdel-Maksoud S; Ahmed WA; Owieda GH
Life Sci; 2005 Mar; 76(18):2125-35. PubMed ID: 15826879
[TBL] [Abstract][Full Text] [Related]
19. Parathyroidectomy has a beneficial effect on experimental cisplatin nephrotoxicity.
Capasso G; Giordano DR; de Tommaso G; De Santo NG; Massry SG
Clin Nephrol; 1990 Apr; 33(4):184-91. PubMed ID: 2350906
[TBL] [Abstract][Full Text] [Related]
20. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
Abu-Amarah I; Balment RJ
Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
